Certificates/Standards: | N; |
Monthly Output: | Not provided |
Regional: | Not provided |
Packaging Information: | Not provided |
Mode Of Payment: | Not provided |
Delivery Lead Time: | Not provided |
Main Sales Markets: | North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa |
Sample Provided: | No |
Sample Policy: | Not provided |
Minimum Quantity: | Not provided |
AmealPeptide® was discovered over the course of around 40 years of continuous research into the physiological functions of fermented milk, produced during the process of manufacturing the lactic acid drink CALPIS®.
Key features include its blood pressure-lowering effects and ability to improve cardiovascular functions. AmealPeptide® has an inhibitory activity against angiotensin converting enzyme(ACE). It works on blood vessels by inhibiting enzymes that cause elevated blood pressure, thereby minimizing increases in blood pressure, and by stimulating production of nitric oxide (NO), which helps to protect blood vessels.
Lactotripeptides (AmealPeptide®) is certified as a “food for specified health use” (FOSHU) in Japan and has been granted GRAS approval in the US.
AmealPeptide® is an Informed-Choice and Informed-Sport certified raw material and each batch undergoes banned substance testing, which reassures elite athletes and drug tested consumers that the AmealPeptide ingredient does not lead to failed anti-doping tests.